DEFUSE 3: Late-Stroke Thrombectomy Benefits All Subgroups DEFUSE 3: Late-Stroke Thrombectomy Benefits All Subgroups

Endovascular therapy shouldn ' t be withheld because of old age, mild symptoms, or late presentation in large-vessel strokes with salvageable brain tissue, subgroup analysis of the DEFUSE 3 trial suggests.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news